MARKET

THRX

Theseus Pharmaceuticals, Inc.
THRX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-50.0469
-
0.7885
181,275,638.32
Weekly Report: what happened at THRX last week (0226-0301)?
Weekly Report · 03/04 09:15
Weekly Report: what happened at THRX last week (0219-0223)?
Weekly Report · 02/26 09:16
Weekly Report: what happened at THRX last week (0212-0216)?
Weekly Report · 02/19 09:17
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Press release · 02/15 00:38
Theseus Pharmaceuticals’ Strategic Merger and Corporate Restructuring
TipRanks · 02/14 15:52
Press Release: Theseus Pharmaceuticals Announces Closing of Tender Offer
Theseus Pharmaceuticals Announces Closing of Tender Offer to acquire all outstanding shares of Theseus common stock. Stockholders to receive $4.05 Per Share in Cash Plus Contingent Value Right. Theseus is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients.
Dow Jones · 02/14 13:30
Weekly Report: what happened at THRX last week (0205-0209)?
Weekly Report · 02/12 09:15
Weekly Report: what happened at THRX last week (0129-0202)?
Weekly Report · 02/05 09:17
More

Webull offers Theseus Pharmaceuticals, Inc. stock information, including NASDAQ: THRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, THRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading THRX stock methods without spending real money on the virtual paper trading platform.